Gunnar Olof Olsson
Chief Executive Officer bij IRLAB THERAPEUTICS AB
Vermogen: 5 836 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Gunnar Olof Olsson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Pharmaceuticals: Major | 16 | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Part of Cambrian BioPharma, Inc., Amplifier TX AB is a Swedish biopharmaceutical company that develops clinical molecule AMPK activators. The private company is based in Umeå, Sweden. The company was founded in 2023 by Thomas Edlund, Helena Edlund. James Hall has been the CEO of the company since 2023.
6
| Holding Company | Biotechnology | 6 |
BioCrine AB
5
| Subsidiary | 5 | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on.
5
| Non-Profit Organization | Miscellaneous Commercial Services | 5 |
Betagenon Bio AB
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gunnar Olof Olsson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GENOVIS AB | Medical Specialties | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer Chairman Director/Board Member Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member | |
Svenskt Näringsliv
 Svenskt Näringsliv Miscellaneous Commercial ServicesCommercial Services Svenskt Näringsliv provides consulting services. It focuses on protection, support, and promotion of the interests of businesses. The firm provides its members with knowledge in a number of areas including labor market and law, taxes, corporate law and intellectual property, economics and macro analysis, constitutional and legal protection, security and risk management, and trade policy. The company was founded on March 29, 2001 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| OREXO AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Director/Board Member Investor Relations Contact Director/Board Member Director/Board Member | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree | |
| University of Uppsala | College/University | Masters Business Admin Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Stockholm | College/University | Director/Board Member Masters Business Admin Graduate Degree | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact General Counsel | |
| Royal Institute of Technology | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| Handelshögskolan i Göteborg | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| LIPIDOR AB | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director of Finance/CFO | |
| KCIF Fund Management AB | Chief Executive Officer Chief Executive Officer | ||
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Private Equity Investor Director/Board Member | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Public Communications Contact Comptroller/Controller/Auditor | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Operating Officer Comptroller/Controller/Auditor | |
| INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Director/Board Member Director/Board Member | |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Founder | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| NANEXA AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| Carlsson Research AB | Founder Founder Founder Chief Tech/Sci/R&D Officer | ||
| ZICCUM AB | Medical Specialties | Corporate Officer/Principal Director of Finance/CFO | |
| ECTIN RESEARCH AB | Biotechnology | Director of Finance/CFO Chairman | |
Balticgruppen Bio AB
 Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Balticgruppen Bio AB is a Swedish biopharmaceutical company that develops activated protein kinase. The company was founded by Olof Karlsson, Thomas Edlund, and Helena Edlund. Thomas Edlund has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Founder Chief Executive Officer | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Director/Board Member Comptroller/Controller/Auditor |
Statistieken
Internationaal
| Zweden | 48 |
| Verenigd Koninkrijk | 3 |
| Verenigde Staten | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 3 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 337 |
| Corporate Officer/Principal | 135 |
| Chairman | 81 |
| Chief Executive Officer | 74 |
| Independent Dir/Board Member | 60 |
Sterkste connecties
- Beurs
- Insiders
- Gunnar Olof Olsson
- Bedrijfsconnecties
